News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
December 16, 2019
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
News
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
News
Pulmonary embolism treatment teams adopted widely for complex disease
November 20, 2019
NEW YORK – The challenge of pulmonary embolism is being increasingly addressed with dedicated teams.
News
Smokers with PE have higher rate of hospital readmission
November 11, 2019
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco dependence.
News
Aspirin for primary prevention reduces risk of CV events, increases bleeding
November 8, 2019
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?
News
Patient-reported complications regarding PICC lines after inpatient discharge
November 4, 2019
What signs and symptoms of possible complications are observed in patients who undergo placement of a peripherally inserted central catheter (PICC)?
News
How should anticoagulation be managed in a patient with cirrhosis?
October 22, 2019
Patients with chronic liver disease have a risk of VTE similar to (or even greater than) that of general medical patients.
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
October 15, 2019
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
News
Ticagrelor monotherapy tops DAPT for high-risk PCI patients
September 29, 2019
SAN FRANCISCO – TWILIGHT findings support move to shorter DAPT.